Seagen Inc.
Quick facts
Phase 3 pipeline
- Taxotere (docetaxel) · Oncology
Taxotere (docetaxel) works by inhibiting cell division, ultimately leading to cell death in rapidly dividing cancer cells.
Phase 2 pipeline
Phase 1 pipeline
- ARRY-380, HER2 inhibitor; oral · Oncology
HER2 inhibitor - SGN-CD19A
- SGN-CD33A
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Seagen Inc.
What is Seagen Inc.'s pipeline?
Seagen Inc. has 1 drugs in Phase 3, 3 in Phase 2, 3 in Phase 1. Late-stage candidates include Taxotere (docetaxel).
Related
- Sector hub: All tracked pharma companies